Dechra appoints new Chief Financial Officer

Veterinary pharmaceutical company Dechra announced Thursday the appointment of Anne-Francoise Nesmes as Chief Financial Officer.

Nesmes joins the company on April 22nd from GlaxoSmithKline where she has worked since 1997 in a number of finance roles including Senior Vice-President, Finance of Vaccines in Belgium.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

The French national, who holds an MBA from Henley Management College and a Master in Management Sciences from Grenoble Business School, started her career in the UK before moving to Belgium, Sweden, and the US.

She will relocate to the UK on taking up her position with the group.

Mike Redmond, Chairman of Dechra, said: "We are delighted that Anne-Francoise is joining Dechra. She is a high calibre finance professional who also has valuable international, pharmaceutical, manufacturing and commercial experience. She will be a welcome addition to the executive team.

"I, and the rest of the board, look forward to working with Anne-Francoise to continue to progress our strategy of delivering a high growth, cash generative, specialist veterinary products business."

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.